Hints and tips:
...worth more than $5bn, according to figures prepared by Dealogic for the Financial Times — Thermo Fisher’s $7.2bn deal for drug ingredients maker Patheon, and Takeda’s $5.4bn takeover of cancer specialist Ariad...
International Edition